Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo-Reference-Cited by-同舟云学术

Liposome Encapsulation of Oncolytic Virus M1 To Reduce Immunogenicity and Immune Clearance in Vivo

Published:2019-01-03 Issue:2 Volume:16 Page:779-785
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Wang Yalong¹,Huang Huizhi¹,Zou Haijuan¹²,Tian Xuyan³,Hu Jun³,Qiu Pengxin³,Hu Haiyan¹^ORCID,Yan Guangmei³

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-sen University, Waihuan East Road 132, Guangzhou Higher Education Mega Center, Guangzhou 510006, P.R. China

2. Department of Pharmacy, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, P.R. China

3. Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Zhongshan II Road 74, Guangzhou 510080, P.R. China

Funder

Ministry of Education of the People's Republic of China

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Guangdong Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01046

Reference31 articles.

1. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

2. New viruses for cancer therapy: meeting clinical needs

3. Oncolytic virotherapy

4. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors

5. REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cationic liposomes overcome neutralizing antibodies and enhance reovirus efficacy in ovarian cancer;Virology;2024-10

2. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

3. Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy;Clinical and Experimental Medicine;2024-08-28

4. Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy;Cancer Immunology, Immunotherapy;2024-07-02

5. Emerging delivery strategy for oncolytic virotherapy;Molecular Therapy: Oncology;2024-06